We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Heart Attack Risk Determined by Specific Genes

By LabMedica International staff writers
Posted on 17 Feb 2009
The genetic risk of suffering a heart attack, regardless of a person's ethnic background, might be predicted by a simple blood test. More...


A group of Canadian and British investigators pinpointed specific genes and their association with an increased risk of heart attack. They extracted DNA from 8,795 individuals of European, south Asian, Arab, Iranian, and Nepalese origin and genotyped 1,536 single nucleotide polymorphisms (SNPs) from 103 genes. SNPs are single base pair variations in DNA, which occur within genes and, in some cases, change the production of proteins or alter the expression of other genes.

The results of the study showed a significant association between four genes, and high cholesterol levels, particularly ApolipoproteinB (ApoB)/A1 levels, which is the primary protein involved in "bad cholesterol" and responsible for carrying cholesterol to tissues. The scientists concluded that 13 common SNPs were associated with heart disease risk factors and one variant was independently associated with the risk of a heart attack.

"Most genetic studies have focused on studying white Caucasians," said Professor Sonia Anand, director of the Population Genomics Program at McMaster University (Hamilton, ON, Canada). "The unique contribution of our study is that we demonstrate that common genetic variants are indeed common across five ethnic groups. Furthermore, we are able to put the contribution of these factors on the risk of heart attack into perspective, demonstrating that the nine risk factors account for the vast majority of heart attacks and the genetic variants while important only add a small independent contribution to the risk of heart attack."

An earlier study led by Professor Salim Yusuf at McMaster University showed that nine risk factors accounted for more than 90% of the risk for heart attacks globally. Those nine risk factors are dyslipidemia/high cholesterol, diabetes, hypertension, abdominal obesity, tobacco, physical inactivity, psychosocial stressors, low fruit and vegetable intake, and no alcohol consumption. Together with the genetic variants (SNPs), the prediction of risk of myocardial infarction (MI) was increased by 1.6%.

Scientists believe that common SNPs may be associated with the development of a number of chronic diseases such as cancer, diabetes, vascular disease, and some forms of mental illness.

Related Links:

McMaster University



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.